Mutant ACVR1 Arrests Glial Cell Differentiation to Drive Tumorigenesis in Pediatric Gliomas
Jérôme Fortin(Princess Margaret Cancer Centre), Tak W. Mak(University Health Network), Jong Fu Wong(University of Oxford), Jillian Haight(University Health Network), Andrew Wakeham(Ontario Institute for Cancer Research), Daniel Schramek(Mount Sinai Hospital), Parameswaran Ramachandran(Princess Margaret Cancer Centre), Gonzalo Sánchez‐Duffhues(Leiden University Medical Center), Ida Zarrabi(University Health Network), Peter ten Dijke(Leiden University Medical Center), Annette Wu(Princess Margaret Cancer Centre), Midory Thorikay(Leiden University Medical Center), David J. Goldhamer(University of Connecticut), Robert Siddaway(Great Ormond Street Hospital), Cynthia Hawkins(Hospital for Sick Children), Alex N. Bullock(Discovery Centre), Graham Hill(University Health Network), Ruxiao Tian(Princess Margaret Cancer Centre), Lorraine N. Apuzzo(University of Connecticut), Eleanor Williams(University of Oxford), Annick You-Ten(Ontario Institute for Cancer Research), Bryan E. Snow(University Health Network)
Cited by 98
Related Papers
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas
|Acta Neuropathologica|2012|1k
Regulation of tumour necrosis factor signalling: live or let die
|Nature reviews. Immunology|2015|994
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
|Journal of Clinical Oncology|2016|867
Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes
|Genes & Development|1998|841